Albert David approves ₹5 dividend, appoints Amit Mahla as CEO at AGM

2 min read     Updated on 07 Aug 2026, 10:00 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Albert David Limited concluded its 87th AGM with shareholders approving a ₹5 dividend, the appointment of Amit Mahla as CEO, and remuneration revisions for Arun Kumar Kothari. The meeting saw high participation and near-unanimous support for all governance and financial resolutions.

powered bylight_fuzz_icon
47584520

*this image is generated using AI for illustrative purposes only.

Albert David Limited shareholders approved a dividend of ₹5 per equity share of ₹10 each for the financial year ended March 31, 2026, alongside the appointment of Amit Mahla as Whole-time Director & CEO, at the company’s 87th Annual General Meeting (AGM) held on August 6, 2026. The meeting, conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM), saw all seven proposed resolutions pass with requisite majority, signaling strong shareholder backing for the company’s leadership continuity and capital distribution plans.

The AGM was convened in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 108 of the Companies Act, 2013. Arun Kumar Kothari, Executive Chairman, presided over the proceedings. CS Ashok Kumar Daga (CP No. 2948) served as the Scrutinizer for the remote e-voting process, which ran from August 3 to August 5, 2026. The record date for voting eligibility was July 30, 2026.

Key Resolutions Passed

Shareholders voted on ordinary and special business items, including financial statements, dividend declaration, director appointments, and remuneration revisions. All resolutions received overwhelming support from promoter and institutional investors.

Resolution Type Agenda Item Outcome Votes in Favor (% of Total)
Ordinary Adoption of Audited Financial Statements for FY26 Passed 100%
Ordinary Declaration of Dividend of ₹5 per equity share Passed 100%
Ordinary Re-appointment of Ms. Prabhawati Devi Kothari as Director Passed 99.99%
Ordinary Ratification of Cost Auditors’ remuneration for FY27 Passed 100%
Ordinary Regularisation of Mr. Amit Mahla as Director Passed 100%
Special Revision of remuneration for Arun Kumar Kothari Passed 80.80%
Special Appointment of Amit Mahla as WTD & CEO (5-year term) Passed 100%

Arun Kumar Kothari’s remuneration was revised for the period from April 1, 2026, to March 31, 2027. This resolution required shareholder consent under Section 197 of the Companies Act, 2013. Votes cast by interested parties, including Mrs. Vedika Kothari, Mr. Anand Vardhan Kothari, and Kothari Phytochemicals Industries Limited, totaling 667,200 shares, were excluded from the count in compliance with Regulation 23(4) of SEBI LODR.

Leadership and Governance Updates

Amit Mahla was regularized as a Director and subsequently appointed as Whole-time Director & CEO effective June 19, 2026. His five-year term extends until June 18, 2031. His remuneration for the period from June 19, 2026, to March 31, 2027, was also approved by shareholders. Ms. Prabhawati Devi Kothari, who retired by rotation, was re-appointed as a director after offering herself for re-election.

The company also ratified the remuneration payable to its Cost Auditors, M/s. S. Gupta & Co., Kolkata, for the financial year 2026-2027. The approved fee is ₹70,000 plus applicable taxes and out-of-pocket expenses, as recommended by the Audit Committee and approved by the Board.

What the Numbers Show

The unanimous or near-unanimous approval of key resolutions highlights strong alignment between the promoter group and public shareholders. The promoter group held 3,551,958 shares and voted in favor of all resolutions where they were not conflicted. The appointment of a long-term CEO suggests a strategic push for consistent execution and growth planning over the next five years, while the declared dividend reflects the company’s commitment to returning value to shareholders despite maintaining operational stability.

Historical Stock Returns for Albert David

1 Day5 Days1 Month6 Months1 Year5 Years
+12.63%+19.24%+16.16%+20.91%+1.74%+53.32%

How is the appointment of Amit Mahla as CEO expected to influence Albert David Limited's strategic growth trajectory and operational efficiency over his five-year tenure?

What specific initiatives or capital allocation strategies will the company pursue to sustain its dividend payout of ₹5 per share amidst evolving market conditions?

How might the revised remuneration structure for Executive Chairman Arun Kumar Kothari impact the company's governance dynamics and executive compensation benchmarks in the sector?

Albert David Ltd accepts resignation of Dr. Kuntal Ganguly as Head-R&D

1 min read     Updated on 06 Aug 2026, 10:42 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Albert David Limited announced the resignation of Dr. Kuntal Ganguly as Head of R&D, effective August 5, 2026. The departure was attributed to personal reasons, with no further details provided regarding a successor or operational impact.

powered bylight_fuzz_icon
47581923

*this image is generated using AI for illustrative purposes only.

Albert David Limited has accepted the resignation of Dr. Kuntal Ganguly from his position as Head of Research and Development. The resignation is effective from the close of business hours on August 5, 2026. The company cited personal reasons for the departure in its disclosure to stock exchanges.

The intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para-A of Part-A of Schedule III to the said Regulations. The disclosure was submitted to both the Bombay Stock Exchange and the National Stock Exchange of India Limited on August 6, 2026.

Resignation Details

The company provided specific details regarding the change in senior managerial personnel in Annexure-A of the filing:

Particulars Details
Reason for Change Personal reasons
Date of Cessation August 5, 2026 (Close of business hours)
Profile Not applicable
Director Relationships Not applicable

Lalit Lohia, Company Secretary and Compliance Officer of Albert David Limited, signed the disclosure. A copy of the resignation email from the HR Department was enclosed as Annexure-B.

Company Response

In its communication to the exchanges, Albert David Limited expressed appreciation for the services rendered by Dr. Kuntal Ganguly during his tenure with the company. The filing confirmed that there are no disclosed relationships between directors related to this change, as it pertains to a senior managerial position rather than a directorship.

Historical Stock Returns for Albert David

1 Day5 Days1 Month6 Months1 Year5 Years
+12.63%+19.24%+16.16%+20.91%+1.74%+53.32%

Has Albert David Limited announced a timeline or criteria for appointing a successor to the Head of R&D role?

What is the expected impact of this leadership change on the company's current product development pipeline and innovation roadmap?

Are there any pending regulatory approvals or strategic projects that may be delayed due to the departure of Dr. Kuntal Ganguly?

More News on Albert David

1 Year Returns:+1.74%